Početna › Rak grkljana
Kliničke studije za Rak grkljana koje traže sudionike u SAD-u
26 studija za Rak grkljana traži sudionike na lokacijama širom Sjedinjenih Američkih Država.
Gradovi s najviše studija
- Milwaukee, WI8 studija
- Atlanta, GA8 studija
- Chicago, IL8 studija
- Kansas City, MO7 studija
- St. Louis, MO7 studija
- Edison, NJ6 studija
- Pittsburgh, PA6 studija
- Durham, NC6 studija
- Portland, OR6 studija
- Baltimore, MD6 studija
- Cincinnati, OH6 studija
- Richmond, VA6 studija
- New York City, NY5 studija
- Queens, NY5 studija
- Kansas City, KS5 studija
- Naperville, IL5 studija
- Omaha, NE5 studija
- Philadelphia, PA5 studija
- Oklahoma City, OK5 studija
- Ann Arbor, MI5 studija
- Champaign, IL5 studija
- Charleston, IL5 studija
- Danville, IL5 studija
- Overland Park, KS5 studija
- Irvine, CA5 studija
- Cedar Rapids, IA5 studija
- Duluth, MN5 studija
- Fargo, ND5 studija
- Lansing, MI5 studija
- Stevens Point, WI5 studija
- Joliet, IL5 studija
- Peoria, IL5 studija
- Bloomington, IL5 studija
- Wausau, WI5 studija
- Cape Girardeau, MO5 studija
- O'Fallon, MO4 studija
- Erie, PA4 studija
- Des Moines, IA4 studija
- Los Angeles, CA4 studija
- Little Rock, AR4 studija
Po državama
- Arizona5 studija
- Arkansas5 studija
- Colorado7 studija
- Connecticut3 studija
- Delaware3 studija
- Florida8 studija
- Georgia8 studija
- Idaho4 studija
- Illinois9 studija
- Indiana4 studija
- Iowa8 studija
- Kalifornija9 studija
- Kansas7 studija
- Kentucky3 studija
- Louisiana4 studija
- Maryland7 studija
- Massachusetts7 studija
- Michigan6 studija
- Minnesota7 studija
- Mississippi3 studija
- Missouri9 studija
- Montana5 studija
- Nebraska5 studija
- New Hampshire3 studija
- New Jersey7 studija
- New Mexico3 studija
- New York10 studija
- North Carolina8 studija
- North Dakota5 studija
- Ohio11 studija
- Oklahoma6 studija
- Oregon6 studija
- Pennsylvania9 studija
- South Carolina5 studija
- South Dakota3 studija
- Tennessee3 studija
- Texas5 studija
- Virginia7 studija
- Washington3 studija
- Wisconsin9 studija
Nedavno ažurirane studije
Službeni tekst studije (engleski)
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT06589804Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States Population
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT06997068Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 29. ruj 2026. · NCT07195734BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT05136196Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT06980038Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 22. ruj 2026. · NCT05172245Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 14. ruj 2026. · NCT02734537Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 3. ruj 2026. · NCT07156227Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 17. kol 2026. · NCT06532279Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 17. kol 2026. · NCT07441681Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 16. srp 2026. · NCT06662058Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 15. srp 2026. · NCT01365169Integrated Cancer Repository for Cancer Research
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 19 do 110 godina · Oba spola · Ažurirano 29. lip 2026. · NCT02012699Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch HN)
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 23. tra 2026. · NCT07209189Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck Cancer
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 15. tra 2026. · NCT03010150TMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 4. ožu 2026. · NCT06868433A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 19. velj 2026. · NCT07063212Lovastatin and Pembrolizumab for the Treatment of Patients With Recurrent or Metastatic Head and Neck Cancer, LAPP Trial
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 11. velj 2026. · NCT06636734Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 10. velj 2026. · NCT01473784CONFIRM: Magnetic Resonance Guided Radiation Therapy
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 9. velj 2026. · NCT04368702Multi-Site Trial of Navigation vs Treatment as Usual to Improve Initiation of Timely Adjuvant Therapy
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 11. pro 2025. · NCT05793151Phase II Randomized Study of Hypofractionated Versus Conventional Radiotherapy
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 26. stu 2025. · NCT06080503SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
U tijeku regrutacijaOpažajna studija
Sve dobne skupine · Oba spola · Ažurirano 28. lis 2025. · NCT03452774Comparing an Investigational Scan (F-18 NaF PET/CT) to Standard of Care Imaging (F-18 FDG PET/CT) for Evaluating Vascular Complications in Patients Receiving Radiation Therapy for Head and Neck Cancer
U tijeku regrutacijaRana faza 1
Od 18 godina i više · Oba spola · Ažurirano 22. lis 2025. · NCT06914999Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers
U tijeku regrutacijaOpažajna studija
Od 21 do 90 godina · Oba spola · Ažurirano 22. ruj 2025. · NCT00900419Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.